EPAS1 and nonpapillary renal cell carcinoma: HIF-2α is a major oncogenic driver in clear cell renal carcinoma (ccRCC) where HIF-1α acts as tumor suppressor (Kondo et al., 2002; Raval et al., 2005; Gordan et al., 2007; Shen et al., 2011).